バイオシミラー

Generics Bulletin: ジェネリック＆バイオシミラーニュース

Coherus Is Confident After US Ranibizumab Filing

Having seen its development partner Bioeq file with the FDA in December last year, Coherus is confident that it will be a leader in the US biosimilar ranibizumab market targeting Lucentis.

Topic biosimilars deal-trends

Generics Bulletin: ジェネリック＆バイオシミラーニュース

Celltrion's Remsima SC Ready For Early 2020 Launch

Celltrion says it is ready to roll out its Remsima SC subcutaneous infliximab in Europe in the first quarter of 2020, after receiving a formal pan-European marketing authorization from the European Commission.

Topic Biosimilars Launches Regulation

Datamonitor Healthcare: 医療用医薬品の市場調査レポート

The evolving landscape of biosimilars

It is important to understand how the biosimilar market has developed over the past five years. Take a look at some of the key events here.

Topic biosimilars

Generics Bulletin: ジェネリック＆バイオシミラーニュース

Alberta Is Second Canadian Province To Switch To Biosimilars

Alberta has become the second Canadian province to announce a biosimilar switching program, following the example set by British Columbia earlier this year. The move has been welcomed by Biosimilars Canada but criticized by originator-backed body Crohn’s and Colitis Canada.

Topic biosimilars Regulation

Generics Bulletin: ジェネリック＆バイオシミラーニュース

Pfizer Reports 80% Biosimilars Growth In Q3

Pfizer has reported 80% growth in its global biosimilars business for the third quarter of 2020, on the back of recent oncology launches. Though the company’s sterile injectables saw a slight drop in business, Pfizer’s biopharma business saw 4% growth.

Topic Coronavirus biosimilars deal-trends

Pink Sheet: 世界の薬事規制と承認審査に関するニュース

Germany Sets Direction Of Travel With New Biosimilar Guidelines

Germany is for the first time to adopt national guidelines on prescribing biologics and biosimilars in move towards increasing biosimilar uptake.

Topic EU Biosimilars

Chemist + Druggist Data

UK Sees PIP Codes Expand To Cover Hospital Drugs

Chemist + Druggist has expanded its “PIP code” system for UK pharmacy procurement to also encompass hospital drugs.

Topic biopharmaceutical Regulation biosimilars

Generics Bulletin: ジェネリック＆バイオシミラーニュース

Top 50 Generics and Biosimilars Companies

The Annual Top 50 Generics & Biosimilars Companies League Table is here, and Generics Bulletin is sharing its content with you! Connect to league tables and commentary summarizing key developments for the Top 10 companies in generics and biosimilars, part of Generics Bulletin’s annual Top 50 ranking.

Topic biosimilars

Generics Bulletin: ジェネリック＆バイオシミラーニュース

Biosimilars Conference Coverage

Industry analysts from Generics Bulletin are bringing you free insights from their comprehensive biosimilars coverage. Obtain critical industry information covering new biosimilars launches, company strategies, and new biosimilars product development.

Topic biosimilars